Our clients have discovered fist-hand the profound difference between a robotic program that achieves impressive economic and clinical results vs. one destined to struggle fiscally and operationally, even in the face of growing surgical volumes. Many hospital administrators incorrectly believe that da Vinci programs cannot be made cost-effective or sustainable. To these facilities, CAVA delivers a
strong message: Your hospital’s robotic program can succeed and flourish, and we can get you there quickly. The key is recognizing that managing a multi-million dollar da Vinci robotic program requires a completely new level of data analytics, surgical insight, efficiency, teamwork, and management...insights not available through industry, and virtually unknown by the more than 2000 US hospitals with robotic programs. CAVA Robotics’ world-class team—comprised of health economists, robotic medical directors, and change management experts—delivers proprietary, online quantitative and qualitative analytics to diagnose a program’s deficiencies across 18 dimensions of performance. From there, CAVA customizes the most effective corrective pathway to move a struggling robotic program onto a trajectory of excellence, efficiency, surgeon and OR crew alignment, economic sustainability, ROI, and superior clinical outcomes, usually in just a few months. CAVA Robotics is led by CEO and applied health economist Josh Feldstein; Medical Director and robotic surgeon Herb Coussons, MD; and Medical Director and robotic surgeon Rick Low, MD.
